Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion type Assertion NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_head.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion description "[Recurrent (in 1/11 cell lines and 6/53 primary tumors) Keap1 gene alterations were observed in BTC and were especially frequent (4/13, 30.7%) in gallbladder cancer (GBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_provenance.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion evidence source_evidence_literature NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_provenance.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion SIO_000772 18692501 NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_provenance.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion wasDerivedFrom befree-20140225 NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_provenance.
- NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_assertion wasGeneratedBy ECO_0000203 NP591328.RAPDvBvM4_0e6GrzncEGE8c0UH1RyhWxQtBpU9gFKjF_s130_provenance.